Diagnosis, testing, treatment, and outcomes among patients with advanced non-small cell lung cancer in the United States.
Shukui QinJoanna P MacEwanSai Sriteja BoppudiMonica R McClainRichard M O'HaraPaul K PaikPublished in: Cancer medicine (2023)
More than 50% of patients were untested for biomarkers. Patients who were less likely to be tested included men, Black patients, current smokers, patients with squamous aNSCLC, and patients with an ECOG PS of 2+. Patients with positive biomarkers who received NCCN-recommended treatment options had significantly longer OS and PFS.